# Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss

> **NCT07592546** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Alain Dagher** · enrollment: 240 (estimated)

## Conditions studied

- Class I/II Obesity

## Interventions

- **DRUG:** semaglutide

## Key facts

- **NCT ID:** NCT07592546
- **Lead sponsor:** Alain Dagher
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2028-12-01
- **Final completion:** 2030-06-01
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07592546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07592546, "Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT07592546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*